Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Bibrocathol→

Bibrocathol Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
6915-57-7
Molecular formula
C6HBiBr4O3
Molecular weight
649.67 g/mol
Drug class
Bismuth-containing topical ophthalmic antiseptic and astringent
Mechanism of action
Exerts local antiseptic and astringent effects through protein precipitation and interaction with microbial surface components. The exact contribution of bismuth and the organic ligand depends on the formulation.
Indications / reported uses
  • Topical treatment of selected superficial inflammatory and infectious conditions of the eyelid and conjunctiva in countries where bibrocathol ophthalmic products are authorised

Sources: NLM MeSH — Bibrocathol · PubMed — Bibrocathol ophthalmic use · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Bibrocathol Environmental Risk Assessment (ERA) (the Bibrocathol ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.